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Abstract. 
 
Here, we report the localization and charac-
terization of BHKp23, a member of the p24 family of 
transmembrane proteins, in mammalian cells. We find 
that p23 is a major component of tubulovesicular mem-
branes at the 
 
cis
 
 side of the Golgi complex (estimated 
 
density: 12,500 copies/
 
m
 
m
 
2
 
 membrane surface area, or 
 
<
 
30% of the total protein). Our data indicate that 
BHKp23-containing membranes are part of the 
 
cis
 
-
Golgi network/intermediate compartment . Using the 
G protein of vesicular stomatitis virus as a transmem-
brane cargo molecule, we find that p23 membranes are 
an obligatory station in forward biosynthetic mem-
brane transport, but that p23 itself is absent from trans-
port vesicles that carry the G protein to and beyond the 
Golgi complex. Our data show that p23 is not present to 
any significant extent in coat protein (COP) I-coated 
vesicles generated in vitro and does not colocalize with 
COP I buds and vesicles. Moreover, we find that p23 
cytoplasmic domain is not involved in COP I mem-
brane recruitment. Our data demonstrate that microin-
jected antibodies against the cytoplasmic tail of p23 in-
hibit G protein transport from the 
 
cis
 
-Golgi network/
intermediate compartment to the cell surface, suggest-
ing that p23 function is required for the transport of 
transmembrane cargo molecules. These observations 
together with the fact that p23 is a highly abundant 
component in the intermediate compartment, lead us to 
propose that p23 contributes to membrane structure, 
and that this contribution is necessary for efficient seg-
regation and transport.
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T
 
ransport 
 
between different intracellular compart-
ments is believed to be mediated by vesicular carri-
ers that bud from one compartment and then specif-
ically dock and fuse with the membrane of the target
compartment (Palade, 1975). The combined efforts of ge-
netics as well as in vivo and in vitro studies has led to the
discovery of factors that actively participate in vesicle traf-
fic. Most factors identified so far are proteins that cycle be-
tween a soluble, cytosolic form and a membrane-bound
form while exerting their activity. Integral membrane pro-
teins, however, are thought to confer ultimate membrane
identity. They may function as membrane receptors for
soluble factors, enable mutual recognition of membranes
destined to fuse and perhaps catalyze the fusion process it-
self (Pryer et al., 1992; Pevnser and Scheller, 1994; Roth-
mann, 1994; Gruenberg and Maxfield, 1995).
Recently, several new integral membrane proteins have
been identified (Wada et al., 1991; Schimmöller et al.,
1995; Stamnes et al., 1995; Belden and Barlowe, 1996;
Blum et al., 1996; Fiedler et al., 1996; Sohn et al., 1996).
They form a new family of proteins presumably implicated
in vesicular traffic (Stamnes et al., 1995). This family is re-
 
ferred to as the p24 family; their members are small (
 
<
 
24
kD), type I membrane proteins, with a short cytoplasmic
tail (10–15 amino acids). They share at least 30% overall
identity at the amino acid level, but the homology is signif-
icantly higher in certain domains (Stamnes et al., 1995;
Sohn et al., 1996). Several members of this family contain
conserved motifs in their cytoplasmic tails, including two
lysine residues reminiscent of the di-lysine ER retention
signal of type I membrane proteins (KKXX-CO
 
2
 
) (Jack-
son et al., 1990).
Evidence obtained in yeast shows that members of the
p24 family play a role in the secretory pathway. Indeed,
yeast null mutants of the genes encoding for emp24p or
erv25p, two members of the p24 family, display a selective
delay in the secretion of a subset of proteins (Schimmöller
et al., 1995; Belden and Barlowe, 1996). In addition, null
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mutants of 
 
EMP24
 
 contain a reduced number of ER-
derived transport vesicles (Stamnes et al., 1995) and are
defective in the retention of ER resident proteins (Elrod-
Erickson and Kaiser, 1996), suggesting that emp24p con-
tributes to vesicle biogenesis and/or specific cargo selec-
tion. Moreover, since emp24p and erv25p are enriched in
coat protein (COP)
 
1
 
 II–coated vesicles generated in vitro
(Schimmöller et al., 1995; Belden and Barlowe, 1996),
these proteins have been proposed to function as recep-
tors for coat proteins and/or cargo molecules on transport
vesicles. Less is known about the mammalian p24 proteins.
Peptides derived from the cytoplasmic tails of different
p24 proteins have the capacity to recruit cytosolic COP I in
vitro as efficiently as the KKXX-CO
 
2
 
–motifs (Cosson and
Letourneur, 1994; Fiedler et al., 1996; Sohn et al., 1996).
One member of the family, p23, was shown to localize to
the Golgi by immunofluorescence (Sohn et al., 1996), and
to be enriched (together with p24) on COP I vesicles gen-
erated in vitro, suggesting that these proteins may function
as COP I receptors (Stamnes et al., 1995; Sohn et al.,
1996).
In this paper, we report the identification, localization,
and characterization of BHKp23, the hamster ortholog of
rabbit p23 (Sohn et al., 1996). We find that p23 is a, if not
the, major component of 
 
cis
 
-Golgi membranes that be-
long, in part, to the 
 
cis
 
-Golgi network/intermediate com-
partment. We also find that p23 (
 
a
 
) is absent from vesicles
that mediate transport between the 
 
cis
 
-Golgi network/in-
termediate compartment and the Golgi complex; (
 
b
 
) is not
required for membrane association of COP I; and (
 
c
 
) is
not present in COP I–coated vesicles to any significant ex-
tent. Our microinjection studies indicate that p23 is in-
volved in biosynthetic membrane transport. Altogether,
our observations suggest that p23 plays a structural role in
regulating the dynamics/organization of the 
 
cis
 
-Golgi net-
work/intermediate compartment membranes.
 
Materials and Methods
 
Cell Culture and Reagents
 
Monolayers of HeLa cells stably expressing a myc-tagged version of 1,2
 
N
 
-acetylglucosaminyltransferase I (NAGT I), of BHK cells, and of CHO
cells, were grown and maintained as described (Gruenberg et al., 1989;
Nilsson et al., 1993). Vero cells were maintained and infected with tsO45
vesicular stomatitis virus (VSV; Indiana Serotype) as described (Kreis,
1986). For incubation of cells at 15
 
8
 
, 20
 
8
 
, or 31
 
8
 
C, cell culture medium was
replaced by MEM containing 10 mM Hepes, pH 7.4, and 5 mM glucose.
Cycloheximide, brefeldin A (BFA), and nocodazole were from Sigma
Chemical Co. (St. Louis, MO); stock solutions (cycloheximide: 10 mg/ml
in water; BFA: 5 mg/ml in methanol; and nocodazole: 10 mM in DMSO)
were kept at 
 
2
 
20
 
8
 
C.
 
Subcellular Fractionation, Electrophoresis,
and Microsequencing
 
BHK cells were homogenized in isotonic sucrose solution and the mem-
branes of the postnuclear supernatant were fractionated using a flotation
step sucrose gradient (Aniento et al., 1993, 1996). In some experiments,
membrane fractions were further sonicated for 5 min in 0.1 M carbonate,
pH 11, and then centrifuged at high speed. Supernatants and pellet frac-
tions were then analyzed in two-dimensional (2D) gel electrophoresis.
Proteins that were both highly enriched in the pellet fraction and absent
from the soluble fraction were considered as integral membrane protein
candidates.
A combination of IEF and SDS-PAGE (Celis et al., 1990) was used to
resolve proteins in high resolution 2D gels (Emans et al., 1993). The diam-
eter of the IEF preparative gels (loaded with 1 mg protein) was 3.6 instead
of 2.5 mm. Preparative SDS-PAGE gels were stained for 10 min in 45%
methanol, 7.5% acetic acid, containing 0.25% Coomasie brilliant blue R-250.
Gels were destained in 45% methanol, 7.5% acetic acid, washed exten-
sively with water, and then dried under vacuum. Protein spots were cut
out, rehydrated in SDS-PAGE sample buffer, and then incubated at 95
 
8
 
C
for 15 min; the spots of up to 10 gels were concentrated with a second
SDS-PAGE. To avoid protein dilution by band broadening, the stacking
(3% acrylamide) and separating (8% acrylamide) gels were limited to the
width of the sample with spacers. Concentration gels were run at constant
voltage (40 V), and processed as before, but were not dried. The protein
band was digested in matrix with trypsin. Fragments were separated by re-
verse phase HPLC and sequenced by Edman degradation (Emans et al.,
1993).
 
COP Recruitment onto Membranes and Formation of 
COP-coated Vesicles In Vitro
 
The membrane recruitment of cytosolic COP I and the formation of COP
I–coated vesicles was studied in vitro by incubating membranes (0.1 mg/
ml) with rat liver cytosol (3.6 mg/ml) in the presence of an ATP-regener-
ating system and guanosine 5
 
9
 
-
 
O
 
-(3-thiotriphosphate) (GTP
 
g
 
S) (20 
 
m
 
M)
as described (Serafini et al., 1991; Sönnichsen et al., 1996). When indi-
cated, the ATP-regenerating system and/or GTP
 
g
 
S were omitted. To
study COP I membrane association, 200 
 
m
 
l of the reaction mixture were
centrifuged (Airfuge; 30 psi, 6 min). The pelleted membranes were resus-
pended in isotonic sucrose solution, and resedimented at the same speed
to wash unbound COP I. To study COP I–coated vesicles formed in vitro,
we used the protocol of Sönnichsen et al. (1996). A 1-ml sample of the re-
action mixture was layered on top of a step gradient comprising 0.75 ml
30%, 3 ml 35%, 3 ml 40%, 3 ml 45%, 1 ml 50% (wt/wt) sucrose in 250 mM
KCl, 2.5 mM MgCl
 
2
 
, 20 mM Hepes-KOH, pH 7.2, and centrifuged to equi-
librium (SW41; 40,000 rpm, 24 h). Fractions (1 ml) were collected from the
top, diluted with 150 mM KCl, 2.5 mM MgCl
 
2
 
, 20 mM Hepes-KOH, pH
7.2, to 
 
<
 
8% sucrose, and membranes were sedimented by centrifugation
(TLA 100.3; 100,000 rpm, 10 min). Sedimented membranes were solubi-
lized in SDS sample buffer and analyzed by SDS-PAGE and Western
blotting.
 
cDNA Cloning and Expression
 
The nonredundant GenBank/EMBL/DDBJ database at NCBI was
searched with the BLAST program for sequences containing the two pep-
tide sequences of BHKp23. Several expressed sequence tags (ESTs) con-
taining both peptide sequences were identified. A human EST clone
(these sequence date are available from GenBank/EMBL/DDBJ under
accession number T10797) was made available to us by G. Bell (Howard
Hughes Medical Institute Investigator, University of Chicago, Chicago,
IL). Two 16-bp PCR primers were designed for generation of a 340-bp
PCR product using the human EST clone as a template. The PCR product,
coding for part of the open reading frame of human p23, was 
 
32
 
P-labeled
using random hexamer labeling (T7QuickPrime®; Pharmacia Biotechnol-
ogy Inc., Piscataway, NJ). The labeled PCR product was used to screen
(Church and Gilbert, 1984: 58
 
8
 
C) 2 
 
3
 
 10
 
6
 
 plaques from a 
 
l
 
ZAPII (Giga-
pack gold II; Stratagene, La Jolla, CA) cDNA library from BHK cells. 20
out of 76 positive plaques were purified, converted to pBluescript KS
(Stratagene), and analyzed by sequencing. All clones were identical in se-
quence; six were not truncated at the 5
 
9
 
-end and coded for a starting Met
within a consensus Kozak (1989) sequence. One of the latter clones was
sequenced in both directions using sequenase (Amersham Corp., Arling-
ton Heights, IL) and custom oligonucleotide primers using a PRISM 310
Genetic Analyzer (Applied Biosystems, Inc., Foster City, CA).
 
Antibodies
 
Antibodies were raised in rabbits against two peptides within the luminal
domain of BHKp23 (antibodies against luminal peptide 1 [LP1]: KNYEE-
 
1. 
 
Abbreviations used in this paper
 
: BFA, brefeldin A; COP, coat protein;
CT, antibodies against a peptide corresponding to the cytoplasmic tail of
BHKp23; EST, expressed sequence tag; GTP
 
g
 
S, guanosine 5
 
9
 
-
 
O
 
-(3-thio-
triphosphate); LP1 and LP2, antibodies against luminal peptides 1 and 2;
NAGT I, 1,2 
 
N
 
-acetylglucosaminyltransferase I; PFA, paraformaldehyde;
2D, two dimensional; VSV, vesicular stomatitis virus. 
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IAKVE, and against luminal peptide 2 [LP2]: RLEDLSESIVNDFAY),
and against a peptide corresponding to the cytoplasmic tail of BHKp23
(CT: TWQVFYLRRFFKAKKLIE). For affinity purification, the anti-
gens were coupled to Affi Gel 10 (Bio-Rad Laboratories, Hercules, CA)
as described by the manufacturer; antibodies were then bound to the cou-
pled antigen in 10 mM Tris, pH 7.4, and eluted with 0.1 M glycine, pH 2.5.
Antibodies were biotinylated with biotinyl-
 
e
 
-aminocaproic acid 
 
N
 
-hydroxy-
succinimide ester (Gruenberg and Gorvel, 1993). Fab fragments of anti-
bodies were prepared with papain immobilized on beads (Pierce Chemical
Co., Rockford, IL) according to the instructions of the manufacturer.
Rabbit antisera against the EAGE epitope of 
 
b
 
-COP (Pepperkok et al.,
1993), the mammalian KDEL receptor, ERD2 (Griffiths et al., 1994), and
TGN38 (Luzio et al., 1990) were gifts of T.E. Kreis (University of Geneva,
Geneva, Switzerland), H.D. Söling (University of Göttingen, Göttingen,
Germany), and G. Banting (University of Bristol, Bristol, United King-
dom), respectively. Mouse mAb against 
 
b
 
-COP (maD: Pepperkok et al.,
1993; and M3A5: Allan and Kreis, 1986), ERGIC-53 (G1/93: Schweizer et
al., 1988), and 
 
b9
 
-COP (CM1A10: Orci et al., 1993; Lowe and Kreis, 1996)
were provided by T.E. Kreis, H.P. Hauri (University of Basel, Basel, Swit-
zerland), and J. Rothman (Sloan-Kettering Institute, New York), respec-
tively. Mouse mAbs that recognize the myc epitope (9E10: Evan et al.,
1985), a cytoplasmic epitope of VSV-G (P5D4: Kreis, 1986), and an exo-
plasmic epitope of VSV-G (17.2.21.4: Gruenberg and Howell, 1985; and
VG: Pepperkok et al., 1993) have been described. Fluorescein-labeled,
anti–mouse IgG, rhodamine-labeled, anti–rabbit IgG, and fluorescein-
labeled streptavidin were from Jackson Immunoresearch Laboratories,
Inc. (West Grove, PA). Unspecific control rabbit IgGs were from Sigma
Chemical Co.
 
Immunofluorescence Microscopy and Microinjection
 
Cells were grown on glass coverslips and fixed with either methanol
(
 
2
 
20
 
8
 
C, 
 
>
 
5 min) or paraformaldehyde (PFA; 20
 
8
 
C, 
 
>
 
20 min). PFA-fixed
cells were permeabilized for 5 min with 0.1% (wt/vol) saponin in PBS. An-
tibodies were diluted in 10% goat serum, 0.1% saponin in PBS. For dou-
ble labeling with mouse and rabbit antibodies, cells were incubated with
the mixture of primary antibodies for 30 min, washed three times with
PBS, and then incubated with a mixture of fluorescein-labeled, anti–
mouse IgG and rhodamine-labeled, anti–rabbit IgG for 20 min. For dou-
ble labeling with two rabbit antibodies, cells were first decorated with one
antibody, followed by rhodamine-labeled, anti–rabbit IgG, and then with
biotinylated CT, followed by FITC-streptavidin. Except for microinjec-
tion experiments, samples were analyzed with a confocal laser scanning
microscope (LSM 410 invert; Carl Zeiss Inc., Thornwood, NY) equipped
with an argon and a helium/neon laser for double fluorescence at 488 and
543 nm. Fluorescein and rhodamine signals were recorded sequentially
(emission filters BP510-525 and LP590) using 
 
3
 
63 or 
 
3
 
100 Plan-APO-
CHROMAT oil immersion objectives. For overlay, fluorescein and
rhodamine images were adjusted to similar output intensities and merged
with Photoshop 3.0 (Adobe Systems Inc., San Jose, CA) into a composite
RGB image using a Power Macintosh 7500/100 computer (Apple Com-
puter Co., Cupertino, CA). Capillary microinjection of antibodies into
cells was performed with an automated microinjection system (Zeiss AIS;
Carl Zeiss Inc.) (Ansorge and Pepperkok, 1988) as described (Pepperkok
et al., 1993). Microinjection experiments were analyzed with an inverted
microscope (Axiovert 135TV; Carl Zeiss Inc.) equipped with a cooled
CCD camera (CH250, 1317 
 
3
 
 1035 pixels; Photometrics Ltd., Tucson, AZ,
USA), controlled by a Power Macintosh 8100/100 (Apple Computer Co.).
Images were further processed with the software package IPLab spectrum
V3.0 (Signal Analytics Corp., Vienna, VA). Ts-O45-G specific cell surface
labeling was quantified as described (Pepperkok et al., 1993). Briefly, cells
were fixed with 3% PFA and incubated for 15 min with antibody 17.2.21.4
(specific for a luminal epitope of the viral glycoprotein), followed by a
rhodamine anti–mouse secondary antibody. Microinjected antibodies
were detected by subsequently permeabilizing the cells with 0.1% Triton
X-100, followed by incubation with fluorescein anti–rabbit antibodies
(Sigma Chemical Co.). Final figures were arranged with PowerPoint 4.0
(Microsoft, Bellevue, WA) and printed on a Kodak Digital Science 8650
PS Color Printer (Eastman Kodak, Rochester, NY).
 
Electron Microscopy
 
To label the endosomal compartments with an electron-dense marker,
BHK cells were incubated for 60 min at 37
 
8
 
C in the presence of 5 nm
BSA-gold (Ludwig et al., 1991). The cells were then washed in ice-cold
PBS, and processed for cryosections and immunogold labeling as de-
scribed (Griffiths et al., 1984). Membrane fractions were sedimented by
centrifugation (TLS-55; 55,000 rpm, 30 min), and then the pellet was fixed
at room temperature with 8% PFA in 250 mM Hepes, pH 7.4, for 1 h. The
solution was replaced with fresh fixative and samples were fixed for at
least another 24 h. Fixed fractions were then processed for immunoelec-
tron microscopy as described (Bomsel et al., 1990). Cryosections of BHK
cells were immunolabeled for p23 and ERD2. Over 200 immunogold par-
ticles were counted, and the percentage of gold particles associated with
the different structures was calculated. In intact cells, continuities between
membranes were more difficult to judge than in fractions and so colocal-
ization of p23 and ERD2 was based on proximity of 
 
,
 
100 nm. For quanti-
tation of p23 labeling of the M2 fraction, cells were double labeled for p23
and ERD2 (untreated fractions), or p23 and 
 
b
 
-COP (GTP
 
g
 
S-treated frac-
tions). In each case, 
 
.
 
300 p23 gold particles were counted. Positive colo-
calization was judged by the presence of p23 and ERD2/
 
b
 
-COP labeling
on the same membrane. The average linear density of p23-labeling on iso-
lated membranes was 100 gold particles/
 
m
 
m. Assuming a section thickness
of 80 nm and a labeling efficiency of 10% (values that are in the range of
previous estimates) (Griffiths, 1993), an estimate of 12,500 p23 molecules/
 
m
 
m
 
2
 
 membrane surface area was obtained.
 
Analytical Techniques
 
For standard SDS-PAGE (Laemmli, 1970), Protean gel II minigel system
(Bio-Rad Laboratories, Hercules, CA) was used. For Western blotting,
proteins were transferred onto nitrocellulose (0.4-
 
m
 
m pore size, Schlei-
cher & Schuell, Inc., Keene, NH) using a semi dry transfer chamber (Bio-
Rad Laboratories), and then stained with PROTOGOLD
 
®
 
 (British Bio-
Cell International, Cardiff, United Kingdom). Antibodies were detected
by chemiluminescence with SuperSignal
 
TM
 
 (Pierce Chemical Co., Rock-
ford, IL), protein was determined with bicinchoninic acid (Pierce Chemi-
cal Co.).
 
Results
 
p23 Is a Member of the p24 Family of Proteins
 
We identified in a light membrane fraction of BHK cells a
polypeptide of 23 kD (see below, Fig. 1 
 
C
 
), which was re-
sistant to membrane extraction by carbonate treatment at
pH 11, a behavior characteristic for transmembrane pro-
teins. The protein was relatively abundant, as it could be
visualized by protein stain in a total cellular extract (not
shown). Microsequencing of p23 revealed that two tryptic
fragments (Fig. 1 
 
A
 
, 
 
LP1
 
 and 
 
LP2
 
) corresponded to the
sequences of several human ESTs. These ESTs shared se-
quence homology to emp24p, a yeast protein involved
in biosynthetic membrane transport (Schimmöller et al.,
1995). Several homologues of emp24p have been identi-
fied, including in mammalian cells, and all these form a
novel family of transmembrane proteins (Fig. 1 
 
B
 
). We
used nucleic acid probes generated from one human EST
clone to screen a BHK cDNA library, and obtained sev-
eral cDNA clones that were identical in sequence. They al-
ways coded for both peptide sequences (Fig. 1 
 
A
 
), but dif-
fered in length towards the 5
 
9
 
 end. The clones containing a
putative initiator methionine within a consensus Kozak se-
quence (Kozak, 1989) coded for an open reading frame of
219 amino acids (these sequence data are available from
GenBank/EMBL/DDBJ under accession number AJ001513).
The open reading frame of the isolated cDNA clones was
found to be 
 
.
 
97% identical at the amino acid level to
Tmp21, a protein by then identified in human and rat
(Blum et al., 1996: these sequence data are available from
GenBank/EMBL/DDBJ under accession numbers X97442
and X97443) and to rabbit p23 (Sohn et al., 1996; Gen-
Bank/EMBL/DDBJ under accession number X98303). 
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BHKp23 exhibits significantly more homology to these
three proteins (
 
>
 
95%) than to any other member of the
p24 family (20–30%; Sohn et al., 1996), indicating that it
may correspond to the hamster ortholog of human/rat
Tmp21 and rabbit p23 (Fig. 1 
 
B
 
).
The hydropathy analysis (not shown) revealed two
strongly hydrophobic stretches: a putative transmembrane
domain near the COOH terminus (Val186–Phe206/Leu208)
and a predicted signal peptide at the NH
 
2
 
 terminus (Met1-
Ala31; Nielsen et al., 1997). The type I membrane topol-
ogy was confirmed by treating intact membranes with
trypsin or proteinase K. Western blot analysis using anti-
bodies against two NH
 
2
 
-terminal epitopes (see below) re-
vealed a small decrease in the relative molecular mass of
p23 after protease treatment. In contrast, both NH
 
2
 
-termi-
nal epitopes were digested by proteases in the presence of
detergent (not shown). The predicted values for molecular
mass and isoelectric point of the mature polypeptide (21.7
and 6.03 kD) agreed well with those determined by 2D gel
electrophoresis (Fig. 1 
 
C
 
, 24.0 and 6.5 kD). Although the
amino acid sequence contains a consensus site for Asn gly-
cosylation (Asn179) (Fig. 1 
 
A
 
), BHKp23 was not glycosy-
lated in vivo: treatment with 
 
N
 
-glycosidase F did not affect
protein mobility in SDS gels (not shown), consistent with
the fact that that Asn179 is too close to the transmem-
brane domain for glycosylation to occur (Nilsson and von
Heijne, 1993).
 
p23 Localizes to Tubulovesicular Membranes and 
Cisternae at the cis Side of the Golgi Apparatus
 
To characterize p23, we generated several rabbit antisera.
As antigens, we used the two luminal peptides that were
originally microsequenced (compare with Fig. 1 
 
A
 
), and a
peptide of the COOH-terminal domain (compare with
Fig. 1 
 
A
 
). The antibodies were affinity purified and charac-
terized by Western blot analysis of 2D gels of the light
membrane fraction; the antibodies decorated p23 in a
highly specific manner (Fig. 1 
 
C
 
). Moreover, both Western
blot and immunofluorescence signals (see below) were
abolished after competition with the immunogenic peptide
(not shown).
Immunofluorescence with anti-p23 antibodies revealed
perinuclear structures with a Golgi-like aspect in different
cell types (Fig. 2, BHK and HeLa; see Fig. 7, CHO and
 
Figure 1.
 
p23 is a member of the p24 family of proteins. (
 
A
 
)
cDNA-derived amino acid sequence of the BHKp23 precursor.
The predicted cleavage site for the signal peptidase is indicated
by an arrowhead. The peptides used for generation of antibodies
are boxed and their names given in italics. Peptides LP1 and LP2
were identified by microsequencing. The consensus site for gly-
cosilation is underlined, the putative transmembrane domain is
typed in bold characters. These sequence data are available from
GenBank/EMBL/DDBJ under accession number AJ001513. (
 
B
 
)
Dendogram of the p24 family. Only those proteins whose full-
length sequence is known were analyzed, the accession numbers
are indicated in parenthesis. Alignment and dendogram were
performed with programs of Genetics Computer Group (Madi-
son, WI). From the known yeast proteins mammalian p23 dis-
plays the highest similarity to yeast erv25p. (
 
C
 
) Characterization
of antibodies against BHKp23. A membrane fraction enriched
for p23 (interface M2 of Fig. 7) was subjected to 2D gel electro-
phoresis, blotted onto nitrocellulose, and then stained with PRO-
TOGOLD (protein stain) or with LP1, LP2, or CT. The p23 protein
(
 
arrowhead
 
) was already detected by protein stain and was specifi-
cally decorated with all three antibodies. Lines indicate the posi-
tion of molecular mass markers (200, 116, 97, 66, 45, 31, and 22 kD). 
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Vero; MDCK, not shown). Similar patterns were observed
using two different antibodies, CT and LP1, and two dif-
ferent fixation protocols (PFA and methanol). This distri-
bution closely resembled that of rabbit p23 (Sohn et al.,
1996). As shown in Fig. 2, p23 overlapped with NAGT I
(Fig. 2, 
 
a
 
 and 
 
b
 
) and the KDEL-receptor ERD2 (Fig. 2, 
 
c
 
and 
 
d
 
). Whereas NAGT I is restricted to medial Golgi cis-
ternae (Nilsson et al., 1993), the KDEL receptor, ERD2,
has been localized both to the Golgi stack and to the inter-
mediate compartment between ER and Golgi (Tang et al.,
1993; Griffiths et al., 1994). In addition, p23 partially over-
lapped with ERGIC-53, but only within the perinuclear
Golgi area (Fig. 2, 
 
e
 
 and 
 
f
 
). Indeed, ERGIC-53 is used as a
marker of the intermediate compartment (Schweizer et
al., 1988, 1990), but the protein cycles between ER and
Golgi (Lippincott-Schwartz et al., 1990) and a significant
fraction of ERGIC-53 molecules localize to the ER at
steady state in several cell types (Hans P. Hauri, personal
communication) (Fig. 2 f, HeLa cells).
To better investigate the distribution of p23, we used no-
codazole. This drug causes microtubule depolymerization
and the appearance of small Golgi stacks scattered through-
out the cytoplasm (Rogalski and Singer, 1984; Cole et al.,
1996). After depolymerization of microtubules with no-
codazole (not shown), p23 appeared scattered throughout
the cytoplasm (Fig. 3), as did all Golgi markers we tested
(Fig. 3). The p23 membranes were positive for both ERD2
(Fig. 3, ERD2) and ERGIC-53 (Fig. 3, ERGIC-53). Whereas
the distributions of p23 and ERD2 largely overlapped
(Fig. 3, ERD2), numerous ERGIC-53–positive membranes,
presumably derived from the ER, were negative for p23
(Fig. 3, ERGIC-53). Within the dispersed Golgi stacks,
p23 was partially segregated from the medial-Golgi en-
zyme NAGT I (Fig. 3, NAGT I) and completely separated
from the trans-Golgi protein TGN38 (Fig. 3, TGN38)
(Luzio et al., 1990). The differential degree of colocaliza-
tion of p23 with proteins of the Golgi and of the cis-Golgi/
intermediate compartment suggested that p23 localizes to
the cis side of the Golgi apparatus.
The distribution of p23 was further investigated by im-
munogold labeling of BHK cryosections (Fig. 4). The label
was exclusively found on tubulovesicular membranes at
one side of the Golgi apparatus, as well as on cisternae of
the Golgi stack (Fig. 4 A; Table I, intact cells). In good
agreement with our immunofluorescence studies (Figs. 2
and 3), ERD2 colocalized with p23 on these membranes
(Fig. 4 B). In fact, a quantitative analysis of the micro-
graphs revealed that ERD2 and p23 colocalized to 100%
(Table I, intact cells). Previous studies showed that the
KDEL receptor, ERD2, localizes to the Golgi stack and to
the intermediate compartment by immunoelectron mi-
croscopy (Griffiths et al., 1994), and to the cis-Golgi and
the intermediate compartment by immunofluorescence
(Tang et al., 1993). We can thus conclude that p23 local-
izes, together with ERD2, to tubulovesicular membranes
and cisternae on the cis side of the Golgi, which may corre-
spond to the ill-defined cis-Golgi network/intermediate
compartment (Rambourg and Clermont, 1990; Schweizer
et al., 1990).
After Brefeldin A or Low Temperature Treatments
p23 Localizes to the Intermediate
Compartment between ER and Golgi Apparatus
The distribution of p23 suggested that the protein localizes
to early biosynthetic membranes at the cis side of the
Golgi complex. BFA causes COP I release from Golgi
membranes, and the relocalization of Golgi proteins to the
ER (Klausner et al., 1992). In contrast, ERGIC-53/p58,
ERD2, and other proteins of the cis-Golgi/intermediate
compartment (gp74, p210, and GM130), remain well sepa-
rated from the ER after BFA treatment (Lippincot-
Schwartz et al., 1990; Saraste and Svensson, 1991; Tang et
al., 1993; Alcalde et al., 1994; Rios et al., 1994; Nakamura
et al., 1995). After treatment of HeLa cells with BFA, the
distribution of COP I proteins changed within minutes
from the typical Golgi pattern to a cytoplasmic staining
(not shown), and NAGT I was relocalized to the ER (Fig.
5 f). In contrast, p23 did not redistribute to the ER, but ap-
peared within discrete punctate structures (Fig. 5, a, c, and
e), which were also positive for both ERGIC-53 (Fig. 5 b)
and ERD2 (Fig. 5 d). These observations confirmed that
ERGIC-53 (Lippincott-Schwartz et al., 1990; Saraste and
Figure 2. Immunolocalization of p23 to the perinuclear Golgi
area. The p23 protein was decorated with antibody LP1 (a and e,
HeLa) or CT (c, BHK). Double immunofluorescence with myc-
tagged NAGT I (b), the KDEL receptor, ERD2 (d), and ERGIC-
53 (f) is shown. Bar, 5 mm.The Journal of Cell Biology, Volume 139, 1997 1124
Svensson, 1991) and ERD2 (Tang et al., 1993; Scheel et al.,
1997) do not redistribute to the ER upon BFA treatment.
Changes in p23 distribution caused by BFA may indicate
that the steady-state distribution of p23 relies on constant
(re)cycling between early biosynthetic compartments, as
has been observed for other proteins with a similar subcel-
lular distribution (compare with Lippincott-Schwartz et
al., 1990; Alcalde et al., 1994). Alternatively, it is also pos-
sible that changes in p23 distribution caused by BFA are
due to drug-induced changes in membrane organization.
More importantly, these experiments showed that p23 ex-
hibited the typical behavior of cis-Golgi/intermediate
compartment proteins after BFA treatment.
The intermediate compartment was originally defined
as the site where proteins destined to the plasma mem-
brane accumulate at 158C (Saraste and Kuismanen, 1984).
We therefore investigated the relationships that may exist
between p23 and the “158C-intermediate compartment.”
We used the tsO45 mutant of the VSV glycoprotein G
(tsO45-G), as a marker of the 158C-intermediate compart-
ment. The tsO45-G protein remains misfolded in the ER
at the nonpermissive temperature of 39.58C, and is prop-
erly folded and transported to the plasma membrane at
318C (Bergmann et al., 1981). Like other cargo molecules,
tsO45-G accumulates in the intermediate compartment at
158C (Schweizer et al., 1990; Lotti et al., 1992; Pepperkok
et al., 1993; Griffiths et al., 1995). Vero cells were infected
with VSV tsO45, and then incubated at 39.58C for 2.5 h to
allow synthesis and accumulation of tsO45-G in the ER.
Cycloheximide was added to inhibit further protein syn-
thesis and the cultures were brought to 158C for 3 h. Cells
were then processed for immunofluorescence and deco-
rated with antibodies against p23 an tsO45-G. As expected,
tsO45-G accumulated in the intermediate compartment
and did not reach the plasma membrane (Fig. 6, 09, VSV-
G). More importantly, tsO45-G then colocalized with p23
in the intermediate compartment (Fig. 6, 09, overlay).
The effects of the “158C block” are fully reversible and
membrane traffic is re-established after shift back to 318C
(Saraste and Kuismanen, 1984). After release from the
158C block, it is thus possible to analyze and compare the
transport routes of different proteins (Griffiths et al., 1995;
Figure 3. Immunolocalization of p23 after mi-
crotubule disruption with nocodazole. HeLa
cells were treated with 10 mM nocodazole for 2 h
to induce the formation of dispersed Golgi
stacks, were fixed, and then processed for dou-
ble immunofluorescence with antibodies against
p23 and ERD2, ERGIC-53, myc-NAGT I, or
TGN38. For double immunofluorescence of
p23 with ERD2 or TGN38, biotinylated CT an-
tibody was revealed with streptavidin-FITC.
Fluorescein and rhodamine channels were
merged (overlay) after adjustment of both fluo-
rescence signals to similar levels. The inset
shows a higher magnification of the area indi-
cated by an arrowhead. The p23 signal over-
lapped completely with that of the KDEL re-
ceptor, ERD2, and extensively with that of
ERGIC-53. Numerous ERGIC-53–positive
membranes, corresponding to the ER, did not
contain p23. Segregation of NAGT I and p23
occurred in perinuclear Golgi fragments that
labeled for both markers, and in smaller pe-
ripheral structures that only labeled for p23.
The absence of signal overlap between p23 and
TGN38 was obvious. The colocalization of p23
with proteins of the cis-Golgi (ERD2), and the
segregation of p23 and proteins of the medial
(NAGT I) and trans-Golgi (TGN38) indicates
that p23 localizes to the cis side of the Golgi.
Bar, 5 mm.Rojo et al. p23-dependent Membrane Transport 1125
Tang et al., 1995). After accumulation of tsO45-G at 158C,
cells were shifted to 318C for different times, and then ana-
lyzed by immunofluorescence. Within 3 min after shift, nu-
merous vesicles containing tsO45-G were observed, pre-
sumably corresponding to transport intermediates carrying
tsO45-G towards the Golgi complex (Fig. 6, 39). Strikingly,
these vesicles were devoid of p23 labeling, suggesting that
p23 is absent from vesicles that carry tsO45-G beyond the
intermediate compartment (see also Fig. 9). Between 12
and 30 min, the number of peripheral structures contain-
ing p23 but not ts045-G, probably corresponding to ele-
ments of the cis-Golgi and/or intermediate compartment,
increased (Fig. 6, 129 and 309). During the same time both
labels tended to overlap in the crescent of perinuclear
Golgi membranes. This overlap may not reflect p23 and
tsO45-G colocalization, but the inability to discriminate
Figure 4. Localization of p23 to tubulovesicular membranes in
the cis side of the Golgi. BHK cells were fixed and processed for
frozen sectioning. A shows sections that were labeled with anti-
bodies to p23 (CT) followed by 10 nm protein A–gold (arrow-
heads). Label is associated with tubulovesicular elements pre-
dominantly located in the vicinity of one face of the Golgi
apparatus (G). Note the absence of labeling on other organelles
including the ER surrounding the nucleus (lower left) and endo-
somes labeled with internalized 5 nm BSA-gold (lower right). B
shows sections labeled with antibodies to p23 (CT; 15 nm gold)
and to ERD2 (10 nm gold). The two antibodies colocalize on
Golgi-associated membranes. Bar, 100 nm.
Table I. Quantitation of the Distribution of ERD2 and BHKp23
In intact cells In M2 fractions
Golgi region ER Other
Colocalization
with ERD2
Cisternae
and tubules Vesicles Other
Colocalization
with ERD2
Cist TubVes Total
BHKp23 23 76 99 0 1 100 94 2 4 99
ERD2 19 79 98 1 1 — 91 2 7 —
Intact cells or M2 fractions were processed for cryosectioning and immunolabeled for ERD2 and BHKp23 as in the representative micrographs shown in Figs. 4 and 11. The dis-
tribution of ERD2 and BHKp23 was quantified as described in Materials and Methods. In intact cells the percentage of gold particles present on stacked cisternae (Cist) or tubu-
lovesicular profiles (TubVes) in the Golgi region, endoplasmic reticulum (ER), and other membranes (Other) was quantified. In M2 fraction the percentage of gold particles
present on cisternae and tubular profiles, vesicles (50–80 nm circular profiles), or other membranes was quantified.
Figure 5. p23 localizes to the intermediate compartment after
BFA treatment. HeLa cells were treated with 20 mg/ml BFA for 1 h
and fixed with methanol (a and b) or PFA (c–f). Cells were dou-
ble labeled with antibodies against p23 (a, LP1; c and e, CT) and
ERGIC-53 (b), the KDEL receptor ERD2 (d) or myc-NAGT I
(f). Whereas the medial Golgi enzyme NAGT I relocated to the
ER (f), p23 appeared within discrete punctate structures scat-
tered throughout the cytoplasm (a, c, and e), where it colocalized
(arrowheads) with ERGIC-53 (b) and ERD2 (d). Bar, 5 mm.The Journal of Cell Biology, Volume 139, 1997 1126
between two close but separared fluorescent signals, as
was observed for the steady-state distribution of cis and
medial Golgi markers (Fig. 2). Beyond 30 min, little if any
colocalization of the two proteins could be observed (Fig.
6, 609), while the bulk of tsO45-G had reached the plasma
membrane (not visible in the confocal planes shown in Fig.
6). Altogether, these data indicate that p23 localizes to
membranes that have been defined as intermediate com-
partment after BFA treatment or low (158C) temperature
incubations.
Subcellular Fractionation of p23
To better characterize the p23 protein and p23-containing
membranes, we used subcellular fractionation. BHK cells
were homogenized, a postnuclear supernatant was pre-
pared and the membranes were separated by flotation in a
step sucrose gradient (Aniento et al., 1993, 1996). Both
p23 and ERD2 were highly enriched in the M2 interface
(Fig. 7), in contrast to other proteins of the early biosyn-
thetic pathway that are enriched in the M1 interface
(ERGIC-53: Aniento et al., 1996; p97: Robinson et al.,
1997). We also investigated the distribution of b-COP, a
component of the COP I coat present on transport vesicles
(for review see Kreis et al., 1995) that functions between
Golgi stacks (Orci et al., 1989) and between ER and Golgi
(Pepperkok et al., 1993; Letourneur et al., 1994). Whereas
the bulk of b-COP was soluble after fractionation (Fig. 7),
as expected, the membrane-associated form of b-COP was
enriched in the M1 interface (Fig. 7), consistent with our
previous findings (Aniento et al., 1996). These experi-
ments show that both ERD2 and p23, which colocalized by
immunofluorescence and immunogold labeling of cryosec-
tions, also codistributed by subcellular fractionation.
Localization of p23 and COP I
Electron microscopy studies have localized COP I to the
Golgi complex and to the transitional area between ER
and Golgi (Oprins et al., 1993; Griffiths et al., 1995). More-
over, Sohn et al. (1996) have reported that rabbit p23 is
enriched in COP I–coated vesicles and that p23 cytoplas-
mic tail peptides have the ability to recruit COP I, leading
to the proposal that p23 represents a Golgi-specific recep-
tor for COP I that is involved in the formation of COP
I–coated vesicles. We therefore compared the localization
Figure 6. p23 colocalizes with VSV-G
in the intermediate compartment
at 158C. Vero cells were infected
with VSV tsO45 and maintained for
2.5 h at 39.58C. Cycloheximide was
then added, and tsO45-G was
blocked in the intermediate com-
partment for 3 h at 158C. The tem-
perature was shifted to 318C for the
indicated periods of time, and cells
were processed for double immu-
nofluorescence with antibodies
against p23 (CT) and VSV-G
(P5D4). Images were processed and
merged (overlay) as in Fig. 3. The
inset shows a higher magnification
of the area indicated by an arrow-
head. VSV-G colocalized with p23
in the intermediate compartment at
158C (09). After release of the tem-
perature block, forward transport
of VSV-G resumed, and the degree
of colocalization with p23 gradually
decreased (39, 129, 309, and 609). Bar,
5 mm.Rojo et al. p23-dependent Membrane Transport 1127
of COP I with that of p23. Although both p23 and COP I
exhibited a characteristic Golgi-like, perinuclear localiza-
tion in different cell types, the distribution of the two pro-
teins did not coincide (Fig. 8, CHO, Vero, and HeLa). This
differential distribution was also evident after nocodazole-
induced formation of dispersed Golgi stacks (Fig. 8, HeLa
[1nocodazole]).
In the living cell, structures that appear to emanate from
the 158C-intermediate compartment upon release of this
temperature block have been thoroughly characterized by
fluorescence and electron microscopy (Griffiths et al.,
1995). The majority of these structures is labeled for both
cargo (tsO45-G) and COP I, suggesting that they repre-
sent tsO45-G–loaded, COP I–coated transport vesicles.
We therefore investigated whether p23 was present on
these COP I–labeled structures generated under identical
conditions. Vero cells were infected with VSV tsO45, and
Figure 7. Cofractionation of p23
and ERD2. BHK cells were ho-
mogenized and membranes of
the postnuclear supernatant
were separated in a step sucrose
gradient. In a, fractions were an-
alyzed by Western blot (equal
amounts of protein loaded per
lane), and antibodies were re-
vealed by chemiluminescence.
In  b, the protein content of each
fraction is expressed as a per-
centage of the total amount in
the gradient. The p23 protein
and ERD2 were enriched in the
M2 interface. Cytosolic proteins, including the bulk of b-COP
(a), remained in the load of the gradient (b, 40%).
Figure 8. COP I and p23 distribution. The
indicated cell types were fixed and pro-
cessed for immunofluorescence, or treated
with 10 mM nocodazole for 2 h before fixa-
tion (1 nocodazole). Images were pro-
cessed and merged (overlay) as in Fig. 3.
The inset shows a higher magnification of
the area indicated by an arrowhead.
Whereas both COP I and p23 localized to
the perinuclear Golgi region in all cell
types, the distribution of the two proteins
was clearly different even in the absence
of nocodazole. It is not clear to what ex-
tent overlapping signal (yellow) is due to
colocalization of the proteins or to super-
imposition of two close but separated fluo-
rescent signals. Bar, 5 mm.The Journal of Cell Biology, Volume 139, 1997 1128
the tsO45-G protein was accumulated in the intermediate
compartment at 158C. Cells were then shifted to 318C for
different times and processed for immunofluorescence
with antibodies against COP I and p23 (Fig. 9). We found
that incubations at 158C caused COP I to colocalize with
p23 on intermediate compartment membranes (Fig. 9, 09),
as predicted from the known effects of this temperature on
COP I distribution (Griffiths et al., 1995). However, im-
mediately after release of the temperature block numer-
ous vesicles appeared that contained COP I, but were de-
void of p23 (Fig. 9, 39 and 69). These observations suggest
that COP I–coated vesicles formed on the membranes of
the intermediate compartment are devoid of p23, in agree-
ment with our findings that vesicles carrying tsO45-G be-
yond the intermediate compartment do not contain signifi-
cant amounts of p23 (Fig. 6, 39).
Interactions of COP I with p23 Membranes
Cytoplasmic tail peptides of p23 were reported to have the
ability to recruit COP I in vitro (Sohn et al., 1996). We
then investigated whether p23 interacted via its cytoplas-
mic domain with COP I proteins. In these experiments, we
first tested the capacity of membrane fractions containing
high amounts of p23 (M2) or essentially devoid of p23
(M1) to recruit cytosolic COP I in vitro. As shown in Fig.
10 A, the M1 and M2 fractions exhibited essentially the
same COP I–binding capacity (Fig. 10 A, b-COP), despite
the dramatic difference in their p23 content (Fig. 10 A,
p23). To further investigate the role of p23, we repeated
these experiments after BFA treatment of the cells in vivo.
This treatment caused p23 to shift from the M2 to the M1
interface upon fractionation (Fig. 10 A, p23), presumably
because BFA altered the physical properties of p23-con-
taining membranes, by altering their protein composition
through unbalanced transport. Enrichment of p23 was
then lowered in M1 (when compared to M2 without BFA)
because lanes were loaded with equal amounts of protein,
and M1 contained more protein than M2 (Fig. 7 B). De-
spite the marked reduction of p23 content in M2 after the
treatment, little, if any, difference could be observed in the
COP I–binding capacity of the fraction. In the absence of
GTPgS, significantly lower amounts of COP I were associ-
ated to membranes, suggesting that other factors, includ-
ing ADP ribosylation factor (ARF) presumably, were rate
limiting. Also this low, GTPgS-independent binding did
not correlate with p23 distribution. It is conceivable that
COP I binding properties, and perhaps the role of p23, are
modified in the presence of excess ARF. In our experi-
ments, however, cytosol was added in a 36:1 (mg protein)
Figure 9. COP I and p23 colo-
calize in the intermediate com-
partment at 158C, and segre-
gate upon release of the
temperature block. Vero cells
were infected with VSV tsO45
and tsO45-G was blocked in
the intermediate compart-
ment for 3 h at 158C as de-
scribed in Fig. 6. The tempera-
ture was shifted to 318C for the
indicated periods of time, and
cells were processed for dou-
ble immunofluorescence with
antibodies against p23 (CT)
and COP I. Images were pro-
cessed and merged (overlay) as
in Fig. 3. The inset shows a
higher magnification of the
area indicated by an arrow-
head. COP I and p23 colocal-
ize in the intermediate com-
partment at 158C (09). Upon
release of the temperature
block (39 and 69), small COP
I–positive structures, that may
represent forward transport
vesicles, are devoid of p23.
Bar, 5 mm.Rojo et al. p23-dependent Membrane Transport 1129
excess over membranes, and ARF is an abundant compo-
nent of the cytosol. In any case, our experiments demon-
strate that the COP-binding capacity of the membranes
did not correlate with their p23 content. Furthermore, these
experiments suggest that the cytoplasmic tail of p23 was
not rate limiting for the association of COP I to membranes.
We then tested whether the CT antibody we raised
against the cytoplasmic domain of p23 interfered with
COP I binding onto membranes containing p23 (Fig. 7 a,
M2). The CT antibody recognizes the cytoplasmic tail of
p23 in Western blots (Fig. 1), in fixed cells (Figs. 2–9), in
cells permeabilized with streptolysin O (unpublished), as
well as in living cells after microinjection (see Fig. 12), and
inhibits biosynthetic protein transport (see Fig. 12). Mem-
branes (25 mg) were incubated with CT antibodies (0, 0.25,
and 2.5 mg) for 2 h at 48C, and then reincubated with cyto-
sol as above and analyzed. Whereas the antibody clearly
bound to membranes under all conditions (Fig. 10 B, CT),
b-COP membrane recruitment in the presence or absence
of GTPgS was completely unaffected by prebound CT an-
tibody (Fig. 10 B, b-COP), even when using a large excess
of CT (12.5 mg, not shown). Conversely, when the mem-
branes were first incubated with cytosol to allow COP
membrane binding to occur, and then with the CT anti-
body, no difference could be detected in antibody binding
to the membranes (Fig. 10 B, CT). This was also true when
COP prerecruitment had been stimulated with GTPgS
(Fig. 10 B, CT). Control antibodies against a luminal pep-
tide of p23, LP2, did not bind to membranes and were
without effect on COP binding (not shown). We also
found that preincubation of the cytosol with either 2 or 20
mM CT-peptide, or with control-peptide (LP2; compare
with Fig. 1 A), had no effect on COP membrane binding
(not shown). These experiments demonstrate that CT an-
tibody and b-COP binding to membranes occur on differ-
ent sites, and thus that the cytoplasmic tail of p23 is not re-
quired for the association of COP I proteins to membranes
in vitro.
Finally, we investigated whether p23 was enriched in
COP-coated vesicles generated in vitro, since enrichment
of rabbit p23 in COP-coated vesicles formed in vitro has
been reported (Sohn et al., 1996). We used the M2 mem-
branes as donor membranes in the assay, since these con-
tained the bulk of p23. Membranes were incubated with
cytosol in the presence of GTPgS (Serafini et al., 1991;
Sönnichsen et al., 1996), and then vesicles formed in vitro
were purified by centrifugation on a sucrose gradient
(Sönnichsen et al., 1996). After centrifugation, donor
membranes and COP-coated vesicles were collected at 26–
32% and 36–42% sucrose, respectively. Membranes were
sedimented and analyzed by SDS-PAGE and Western
blot. Donor membranes that had recruited b-COP clearly
contained the bulk of p23 (Fig. 10 C, yield). In contrast,
very little p23 could be detected in fractions containing
COP I–coated vesicles formed in vitro (Fig. 10 C, yield).
We then investigated whether p23, although present in low
amounts, might be enriched in COP-coated vesicles, by
comparing the p23 and COP content of equal protein
amounts of donor membranes and coated vesicles (Fig. 10
C, enrichment). In contrast to b-COP, which was enriched
in the vesicles formed in vitro, p23 was deenriched in
COP-coated vesicles, when compared to donor mem-
branes (Fig. 10 C, enrichment). Altogether these experiments
demonstrate that BHKp23 is not involved in COP recruit-
ment onto membranes and does not partition to any signif-
icant extent into COP-coated vesicles generated in vitro.
Ultrastructural Organization of p23 Membranes
As a next step, we analyzed the membranes highly en-
Figure 10. In vitro recruitment of COP I. (A) Membranes with
low (M1) and high (M2) p23 content were prepared by subcellu-
lar fractionation. When indicated (1BFA), cells were pretreated
with BFA to shift p23 from M2 to M1 membranes upon fraction-
ation. To recruit COP I onto membranes, fractions (25 mg) were
incubated with cytosol (900 mg) in the presence of the indicated
nucleotides. Membranes were sedimented, washed, and analyzed
by Western blot with antibodies against the indicated proteins.
(B) Membranes (25 mg protein) with high p23 content (M2) were
sequentially incubated; first with increasing amounts of CT, and
then with cytosolic COP I or vice versa. Membranes were sedi-
mented, washed, and analyzed as in A, using antibodies against
rabbit IgG (to reveal bound CT) or against b-COP. To quantitate
the binding of whole anti-p23 IgG molecules (CT), samples were
not boiled in SDS. Lower exposures of this Western blot did not
reveal any differences between untreated and CT antibody–
treated membranes (not shown). (C) COP-coated vesicles were
generated in vitro from donor M2 membranes in the presence of
cytosol, ATP and GTPgS. The mixture was then centrifuged to
equilibrium on a sucrose gradient as in Sönnichsen et al. (1996),
and fractions were collected. Membranes of the donor fraction
(29% sucrose) and of the COP vesicles fraction (40%) were sedi-
mented and analyzed with antibodies against p23 and b-COP.
Analysis of equal volumes of each fraction (yield) reveals that the
bulk of p23 does not partition into COP I–coated vesicles. Analy-
sis of equal protein amounts (8 mg; enrichment) shows that b-COP
is enriched, and p23 is de-enriched, in COP–coated vesicles.The Journal of Cell Biology, Volume 139, 1997 1130
riched in both ERD2 and p23 (Fig. 7 b, M2) by immu-
nogold labeling of cryosections. Strikingly, p23 labeling
was restricted to a discrete subset of membranes whose
structure was reminiscent of cisternae or tubules (Fig. 11
A; Table I, M2 fractions), and very few gold particles were
found on vesicular membranes (Table I, M2 fractions). As
shown in Fig. 11 B (arrowheads), all p23-positive mem-
branes also contained ERD2 (see Table I for quantifica-
tion). Thus, this electron microscopy analysis of the frac-
tions not only confirmed our observations that ERD2 and
p23 colocalize in the same intracellular compartment
(Figs. 2–5), but demonstrated that they distribute to the
very same membranes.
Immunogold labeling of the isolated membranes was
significantly improved, when compared to intact cells
(compare with Fig. 4), presumably because of better anti-
gen accessibility after cell homogenization (Griffiths, 1993).
This analysis thus also revealed that p23 was extremely
Figure 11. p23 is an abun-
dant component of tubulove-
sicular or cisternal mem-
branes that also contain the
KDEL receptor, ERD2.
Fractions enriched for p23
(fraction M2) were fixed and
processed for frozen section-
ing (A and B) or were
treated with GTPgS in the
presence of cytosol before
fixation (C). A shows sec-
tions labeled for p23 (CT; 15
nm protein A–gold). Dense
labeling is associated with
the cytoplasmic surface of
abundant tubular profiles
(indicative of either cisternal
elements or tubules). Note
that the labeling sometimes
appears to show polarized
distribution lining only one
surface domain of the tubule
(e.g.,  arrowheads).  B shows
a section labeled for p23 (CT;
15 nm gold) and ERD2 (10
nm gold; arrowheads). The
two markers colocalize on tu-
bular elements. C shows a
fraction incubated with GTPgS
and cytosol before fixation.
The section was labeled with
antibodies to p23 (CT; 15 nm
gold) and b-COP (EAGE-
epitope, 10 nm gold; arrow-
heads). The two proteins
show colocalization on tubu-
lar elements, but COP-labeled
buds and vesicles are nega-
tive for p23. Bar, 100 nm.Rojo et al. p23-dependent Membrane Transport 1131
abundant on these cis-Golgi network/intermediate com-
partment membranes. We could estimate that the density
of p23 corresponded to 12,500 molecules/mm2 membrane
surface area (Materials and Methods), and thus that p23
may account for up to 30% of the total integral membrane
proteins in these membranes (Quinn et al., 1984).
We have established that p23 membranes were able to
recruit COP I coats (Fig. 10), but that the cytoplasmic do-
main of p23 was not involved in this process (Fig. 10, A
and B). We also established that p23 molecules did not
preferentially partition into COP I–coated vesicles (Fig. 10
C). When analyzed by electron microscopy, p23 mem-
branes were devoid of b-COP (not shown), in agreement
with our fractionation studies (Fig. 7). To further charac-
terize the recruitment of COP I coats, p23 membranes of
the M2 fraction (Fig. 7) were incubated with cytosol, an
ATP-regenerating system, and GTPgS as described above.
Membranes were sedimented, and analyzed by electron
microscopy using antibodies against b-COP and p23. As
expected, in addition to tubulovesicular membranes, nu-
merous coated buds and vesicles were then visible (Fig. 11
C). Fig. 11 C clearly shows that p23 and b-COP (arrow-
heads) colocalized on tubular elements, demonstrating
that p23 membranes were competent to recruit COP I, as
shown in Fig. 10. In contrast, a quantitative analysis dem-
onstrated that the vast majority (<80%) of COP I–posi-
tive vesicles and buds were negative for p23 (Fig. 11 C; and
Table II). These observations strongly suggest that the
fraction of p23 incorporated within COP I–coated mem-
branes was too low to be detected. In good agreement with
our biochemical studies (Fig. 10 C), this morphological
analysis confirmed that p23 was less abundant on COP
I–coated vesicles than on purified p23 membranes.
Antibodies Against the Cytoplasmic Tail of p23
Inhibit Transport of ts045-G through the cis-Golgi 
Network/Intermediate Compartment
Since we found that ts045-G transiently colocalized with
p23 in the intermediate compartment between ER and
Golgi apparatus (Fig. 6), we investigated whether p23 par-
ticipated in ts045-G transport. Previous studies had shown
that microinjection of specific antibodies is a powerful ap-
proach to study protein function in vivo. Indeed, microin-
jected antibodies against the cytoplasmic tail of VSV-G
(Kreis, 1986) and against b-COP (Pepperkok et al., 1993)
inhibit VSV-G transport to the cell surface. We therefore
investigated whether microinjection of antibodies against
the cytoplasmic tail of p23 affected transport of VSV-G to
the plasma membrane.
In these experiments, tsO45-G was accumulated in the
ER at 39.58C, cells were microinjected with antibodies
against the cytoplasmic tail of p23, cycloheximide was
added, and then transport was allowed to resume by low-
ering the temperature to 318C. Fig. 12 shows two identical
microinjection experiments (a and b, and c and d). The mi-
crographs reveal that microinjected antibodies bound to
intermediate compartment membranes (Fig. 12, a and c,
arrowheads), and that excess antibody remained soluble in
the cytoplasm (Fig. 12, a and c). In microinjected cells, the
amounts of tsO45-G that reached the plasma membrane
60 min after releasing the 39.58C block were significantly
lowered when compared to neighboring, non-microin-
jected cells (Fig. 12, b and d). More importantly, tsO45-G
molecules that did not reach the plasma membrane accu-
mulated in intracellular membranes where they partially
colocalized with p23 (Fig. 12, b and d). Microinjection of
control antibodies was without effects (not shown). Quan-
tification of the rate of tsO45-G appearance on the cell
surface confirmed that anti-p23 tail antibodies, but not
control antibodies, significantly inhibited tsO45-G trans-
port. After 60 min, <40% of VSV-G molecules had
reached the cell surface, when compared to the control
(Fig. 12 e). In contrast, microinjection of monovalent Fab
fragments of the same antibodies did not affect tsO45-G
transport to the plasma membrane to any significant ex-
tent (Fig. 12 e). It is possible that Fab fragments exhibited
a decreased avidity/affinity for their antigen and were thus
not as inhibitory as whole IgG molecules. However, micro-
injected Fab fragments also recognized their antigen on the
membranes (not shown). The absence of an effect upon
microinjection of Fab fragments thus suggests that the in-
hibition caused by the intact antibody does not solely rely
on steric hindrance, for example by preventing binding of
soluble factors to p23 cytoplasmic tail, but may be due to
the cross-linking of p23 molecules in the plane of the
membrane (Kreis and Lodish, 1986). These observations
agree with our findings in vitro, showing that antibodies
against the cytoplasmic tail of p23 bind to isolated p23
membranes, but do not interfere with COP I recruitment.
To more precisely characterize the site of p23 action in
forward membrane transport, we then used the same strat-
egy to study and compare the effects of anti-p23 tail anti-
bodies on tsO45-G transport from the intermediate com-
partment to the plasma membrane. After accumulation in
the ER at 39.58C, cycloheximide was added, and ts045-G
molecules were allowed to reach the intermediate com-
partment during a 3-h incubation at 158C. Antibodies were
then microinjected, and cells were further incubated at
318C to allow membrane transport to resume. As shown in
Fig. 12 f, microinjected antibodies, which decorated the in-
termediate compartment (not shown), inhibited forward
transport of ts045-G molecules, whereas control antibod-
ies were without effects. However, when cells were incu-
bated for 3 h at 208C, rather than 158C, to allow transport
of tsO45-G to the TGN before microinjection (Griffiths
and Simons, 1986), antibodies were without effects on
ts045-G appearance on the cell surface (Fig. 10 g). These
experiments rule out possible nonspecific effects of the
anti-BHKp23 tail antibodies, and indicate that p23 is in-
volved in the transport of transmembrane cargo molecules
from the intermediate compartment to the cell surface.
Table II. Quantitation of the Distribution of COP I on 
Structures Labeled with p23 After GTPgS Treatment
Cisternae Vesicles/buds
p231 p232 p231 p232
COP I 14 0 7 79
M2 fractions were incubated with GTPgS, processed for cryosectioning, and then im-
munolabeled for p23 and b-COP (as in the representative micrograph shown in Fig.
11 C). The distribution of b-COP and BHKp23 to cisternal elements or vesicles and
buds was quantified as described in Materials and Methods. The percentage of b-COP
gold particles (COP I) associated with p23-positive (p231) or negative (p232) pro-
files was calculated.The Journal of Cell Biology, Volume 139, 1997 1132
Discussion
We have identified, localized, and functionally character-
ized BHKp23, an integral membrane protein of the
emp24/gp25L protein family. Because of their high degree
of homology, we consider BHKp23 to be the hamster
ortholog of rat/human Tmp21 and rabbit p23 (Blum et al.,
1996; Sohn et al., 1996). In yeast cells, emp24p (Schim-
möller et al., 1995; Stamnes et al., 1995; Elrod-Erickson
and Kaiser, 1996), and erv25p (Belden and Barlowe, 1996)
have been previously reported to play a role in protein se-
cretion. In this paper, we show that mammalian p23 is lo-
calized to the cis-Golgi network/intermediate compart-
ment, and that p23 function is required for biosynthetic
membrane transport.
Subcellular Localization of p23
Several lines of evidence demonstrate that p23 localizes to
the  cis side of the Golgi apparatus, in a specific set of
membranes that presumably belong to the cis-Golgi net-
work/intermediate compartment. Indeed, p23 distributes
within typical tubular elements, distal to the ER and prox-
imal to the cis side of the Golgi complex (Rambourg and
Figure 12. Microinjected an-
tibodies against the cytoplas-
mic tail of p23 decorate the
p23 protein in vivo and in-
hibit the transport of VSV-G
through the intermediate
compartment. Vero cells
were infected with VSV
tsO45 and the tsO45-G pro-
tein was accumulated in the
ER at 39.58C (a–e), in the in-
termediate compartment at
158C (f) or in the TGN at
208C (g). Cells were microin-
jected with CT (5 mg/ml IgG-
CT), with Fab fragments of
these antibodies (2.6 mg/ml
Fab-CT), or with nonspecific
antibodies (10 mg/ml control
IgG). 30 min after injection,
the temperature was shifted
to 318C and cells were fixed
after 60 min (a–d) or after
different times (e–g). Micro-
graphs a and b, and c and d
show two identical microin-
jection experiments, graphs
e–g show the quantitation of
surface (VSV-G) fluores-
cence as a function of time.
Microinjected CT decorated
the p23 protein in vivo (a and
c, arrowheads). After 60 min
at permissive temperature,
surface fluorescence was
lower in microinjected cells
than in neighboring, non-
microinjected cells (b and d).
Intracellular tsO45-G par-
tially colocalized with p23 in
microinjected cells (b and d,
arrowheads), but also accu-
mulated in structures that
were negative for p23 (b and
d,  arrows). Microinjected
CT (e and f, m), but not
monovalent Fab fragments
(e,  d), or control antibodies
(e and f, m) inhibited the transport of VSV-G from the ER (e) or the intermediate compartment (f) to the cell surface. Transport of
tsO45-G from the TGN to the plasma membrane was not affected by either antibody (g). Surface fluorescence was quantitated and
each value was normalized to the surface staining obtained for cells injected with control IgG after 90 min (e and f) or 60 min (g). Each
value represents the mean of two (f and g) or three (e) independent experiments (.50 cells analyzed in each experiment). The maximal
deviation of the mean is indicated. Bar, 15 mm.Rojo et al. p23-dependent Membrane Transport 1133
Clermont, 1990; Schweizer et al., 1990; Lotti et al., 1992).
Like ERGIC-53/p58 (Lippincott-Schwartz et al., 1990; Sa-
raste and Svensson, 1991) and other proteins present in
the cis-Golgi/intermediate compartment (ERD2: Tang et
al., 1993; gp74: Alcalde et al., 1994; GM130: Nakamura et
al., 1995; p210: Rios et al., 1994; GS28: Subramaniam et al.,
1995), p23 does not relocate to the ER after BFA treat-
ment. In addition, p23 colocalizes with newly synthesized
VSV-G, but only when VSV-G export from the intermedi-
ate compartment is blocked at 158C (Saraste and Kuis-
manen, 1984; Schweizer et al., 1990; Lotti et al., 1992).
After release of the temperature block, when forward
transport resumes, small vesicles containing the G protein
are typically devoid of p23.
Although the cis-Golgi network/intermediate compart-
ment is relatively ill defined, the generally accepted view is
that it serves as a major sorting site where proteins are ei-
ther retrieved back to the ER or transported forward
along the biosynthetic pathway (Warren, 1987; Hauri and
Schweizer, 1992; Pelham, 1995). Accordingly, we find a
striking colocalization under all conditions tested between
p23 and ERD2, the KDEL receptor that moves from the
Golgi/intermediate compartment to the ER upon ligand
binding (Lewis and Pelham, 1992). In complete agreement
with these morphological observations, we find that the bulk
ERD2 cofractionates with p23. Since membranes contain-
ing p23 appear to be an obligatory step for VSV-G mole-
cules en route to the Golgi, they are likely to represent the
first site where the KDEL receptor encounters and binds
“escaped” KDEL ligands. The distribution of p23 is differ-
ent from that of ERGIC-53/p58, since ERGIC-53/p58 lo-
calizes to the intermediate compartment and to the ER
(Schweizer et al., 1988, 1990; Lippincott-Schwartz et al.,
1990; Saraste and Svensson, 1991; H.P. Hauri, personal
communication), and because both proteins do not cofrac-
tionate. Our observations, thus, suggest that p23 is primarily
located on a very distinct set of membranes, which corre-
spond to the cis-Golgi network/intermediate compartment, or
to a specialized membrane domain within this compartment.
COP I and p23 Membranes
In mammals, rabbit p23 and CHOp24 have been proposed
to function as COP and/or cargo receptors, as both pro-
teins are enriched in COP I–coated vesicles generated in
vitro (Stamnes et al., 1995; Sohn et al., 1996), and as pep-
tides derived from cytosolic domains of several members
of the p24 family are able to recruit COP I coats (Fiedler
et al., 1996; Sohn et al., 1996). The proposal that coat re-
ceptors exist is attractive because it provides an explana-
tion for the assembly of coats on specific membranes.
However, the notion of a receptor remains speculative,
since numerous transmembrane cargo proteins also inter-
act via precise sequence motifs with coat components
(Trowbridge et al., 1993), including COP I proteins (Cos-
son and Letourneur, 1994). Indeed, the itinerant protein
ERGIC-53/p58, whose cytoplasmic tail has a bona fide di-
lysine, ER retention signal, has been recently implicated in
the membrane association of COP I proteins (Tisdale et
al., 1997).
To investigate the possible relationship between COP I
and p23, we carried out a complete biochemical and mor-
phological analysis of the distribution of both proteins.
Our data show that both b-COP and p23 localize to peri-
nuclear membranes in the Golgi region. However, the dis-
tribution of p23 and b-COP does not significantly overlap,
except when membrane traffic is arrested at 158C. After
release of this temperature block (when membrane traffic
resumes), the degree of colocalization diminishes to steady-
state levels. Moreover, we find that vesicular structures
appearing immediately after release of this temperature
block contain COP I (or VSV-G), as expected, but are typ-
ically devoid of p23. These observations strongly suggest
that p23 is absent from COP I–coated transport vesicles
that carry VSV-G beyond the intermediate compartment.
Accordingly, our biochemical and ultrastructural analysis
of COP I–coated vesicles generated in vitro, in the pres-
ence of GTPgS, demonstrate that p23 is not enriched in
purified COP-coated vesicles, and that the cytoplasmic tail
of p23 is not required for membrane association of COP I
in vitro.
It is difficult at present to provide an explanation for the
discrepancy between our findings and those of Stamnes et
al. (1995) and Sohn et al. (1996). However, our data
strongly suggest that COP I proteins associate to mem-
branes via a p23-independent mechanism, perhaps via
other members of the p24 family (Fiedler et al., 1996), or
KKXX-CO2–containing proteins (Cosson and Letourneur,
1994; Tisdale et al., 1997). Indeed, soluble COP I is able to
interact with peptides carrying a di-lysine motif in vitro
(Cosson and Letourneur, 1994; Fiedler et al., 1996; Sohn et
al., 1996), and this property is relevant for protein traffic in
vivo (Letourneur et al., 1994). However, it is likely that the
interaction of COP I with cytoplasmic tails that carry the
di-lysine motif is subject to further regulations in vivo
(compare with Letourneur et al., 1995).
Function of p23
Our microinjection data suggest that p23 is involved in for-
ward transport of a transmembrane cargo protein, the
ts045 mutant form of the VSV-G glycoprotein. Presum-
ably, p23 is required at the level of the cis-Golgi network/
intermediate compartment, since forward transport is de-
layed when the viral protein is preaccumulated at 158C in
the intermediate compartment. The fact that microin-
jected Fab fragments that decorated the cytoplasmic tail of
p23 were not inhibitory, suggests that inhibition is not solely
caused by preventing association of soluble factors to the
cytoplasmic tail of p23. This is in agreement with the find-
ing that bivalent CT antibodies do not interfere with COP
I membrane binding in vitro. The simplest interpretation is
that the polyvalent antibody binds to more than one p23
molecule causing their lateral association in the plane of
the membrane, and thus interfering with their dynamics.
This may directly affect movement of VSV-G through the
intermediate compartment, and thus delay its transit, and/
or alter the packaging of the viral protein into forming
transport vesicles.
Further work will be required to establish the precise
function of p23. However, we can speculate that p23 con-
tributes to the structure of the cis-Golgi network/interme-
diate compartment. The p23 protein is a relatively abun-
dant cellular protein that can be visualized by protein stainThe Journal of Cell Biology, Volume 139, 1997 1134
on gels of total cellular extracts, and which can be quanti-
tatively recovered after fractionation with a high enrich-
ment (<50-fold). Since only a small subset of membranes
in the fraction contain p23 (<10–20%), and because these
are decorated to a high extent by immunogold particles,
p23 must be highly enriched in these membranes. In fact,
our morphometric studies indicate that the density of p23
in these membranes is <12,500 molecules/mm2 membrane
surface area. For a comparision, the density of spike glyco-
protein molecules in the membrane of enveloped viruses
was estimated to be <22,500 molecules/mm2, a value in the
same range as estimated for integral membrane proteins in
intracellular membranes (<30,000 molecules/mm2; Quinn
et al., 1984). Moreover, caveolin, which is a major struc-
tural component of caveolae, was estimated to be present
in caveolar membranes at a density of 8,000 molecules/
mm2 (Dupree et al., 1993). We can therefore conclude that
p23 is a, if not the, major integral protein of these mem-
branes. These observations, together with the fact that p23
displays heptad repeats of hydrophobic amino acids pre-
dicted to form coiled-coil interactions, suggest that p23
contributes to membrane organization and/or dynamics
via protein–protein interactions.
So far, p23 is the only member of the p24 family that has
been localized in mammalian cells (this work and Sohn et
al., 1996). The cellular distribution of other members of
the family remains to be established. Clearly, future stud-
ies will be required to determine whether members of the
p24 family may or may not fulfill similar functions at dif-
ferent subcellular locations or act synergistically at the same
transport steps. At present, however, our data strongly
suggest that p23-rich membrane domains (presumably in-
volving coiled-coil type interactions) control the dynamics
and organization of the cis-Golgi network/intermediate
compartment, and thereby mediate vesicle formation and
trafficking of a transmembrane protein to the Golgi complex.
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